Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 EUR | -1.27% | -.--% | -8.24% |
Jul. 05 | Belgian finance regulator issues warning about Hyloris Pharmaceuticals | RE |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Chart calendar Hyloris Pharmaceuticals SA
Upcoming events on Hyloris Pharmaceuticals SA
Past events on Hyloris Pharmaceuticals SA
2024-06-03 | Annual General Meeting |
2024-03-14 09:00 am | Q4 2023 Earnings Call |
2024-03-14 02:00 am | Q4 2023 Earnings Release |
2024-01-07 | JPMorgan Healthcare Conference |
2023-11-22 | Degroof Petercam Belgian Day |
2023-11-13 | Jefferies London Healthcare Conference |
2023-11-05 | Bio-Europe Conference |
2023-10-23 | CPHI Conference |
2023-10-08 | De Belegger On Tour |
2023-10-04 | Investor Day |
2023-09-26 | Biotech On Tap Conference |
2023-09-07 10:00 am | Q2 2023 Earnings Call |
2023-09-06 04:00 pm | Q2 2023 Earnings Release |
2023-06-13 08:00 am | Annual General Meeting |
2023-06-04 | BIO International Convention |
2023-04-25 | Kempen Lifesciences Conference |
2023-03-19 | DCAT Conference |
2023-03-16 09:00 am | Q4 2022 Earnings Call |
2023-03-15 02:03 pm | Q4 2022 Earnings Release |
2022-11-23 10:00 am | Business Update Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 0,09 | 0,18 0,95 -81.58% | 3,10 2,65 16.83% | 2,95 5,00 -40.98% | 4,41 7,35 -40.05% | 8,15 |
EBITDA Million EUR | Released Forecast Spread | 0,00 | -4,49 -11,9 62.24% | -4,63 -13,0 64.35% | -10,4 -11,4 8.4% | -15,9 -12,2 -30.22% | -14,6 |
EBIT Million EUR | Released Forecast Spread | 0,00 | -5,08 -8,00 36.56% | -10,5 -13,0 18.92% | -10,6 -12,0 11.35% | -16,2 -12,2 -33.08% | -14,3 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | -7,15 -6,00 -19.08% | -11,3 -8,00 -41.03% | -10,8 -12,0 10.28% | 0,00 0,00 - | -13,0 |
Net income Million EUR | Released Forecast Spread | 0,00 | -7,15 -6,00 -19.08% | -11,6 -13,0 10.93% | -10,8 -12,0 10.25% | -15,8 -9,35 -68.58% | -14,1 |
EPS EUR | Released Forecast Spread | -1,49 | -0,33 -1,71 80.7% | -0,45 -0,53 15.09% | -0,40 -0,45 11.11% | 0,00 -0,60 - | -0,50 |
Announcement Date | 16/06/20 | 09/03/21 | 16/03/22 | 15/03/23 | 14/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 S1 |
---|---|---|
Net sales Million EUR | Released Forecast Spread | 1,03 |
Announcement Date | 01/09/22 |
Past sector events for Hyloris Pharmaceuticals SA
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HYL Stock
- Calendar Hyloris Pharmaceuticals SA